Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
aut.relation.endpage | 662 | |
aut.relation.issue | 5 | |
aut.relation.startpage | 656 | |
aut.relation.volume | 103 | |
aut.researcher | Narayanan, Ajit | |
dc.contributor.author | Glaysher, S | |
dc.contributor.author | Gabriel, FG | |
dc.contributor.author | Johnson, P | |
dc.contributor.author | Polak, M | |
dc.contributor.author | Knight, LA | |
dc.contributor.author | Parker, K | |
dc.contributor.author | Poole, M | |
dc.contributor.author | Narayanan, A | |
dc.contributor.author | Cree, IA | |
dc.contributor.author | NHS Collaborative Research Programme for Predictive Oncology | |
dc.date.accessioned | 2014-12-11T02:05:10Z | |
dc.date.available | 2014-12-11T02:05:10Z | |
dc.date.copyright | 2010-08-24 | |
dc.date.issued | 2010-08-24 | |
dc.description.abstract | Ovarian cancer shows considerable heterogeneity in its sensitivity to chemotherapy both clinically and in vitro. This study tested the hypothesis that the molecular basis of this difference lies within the known resistance mechanisms inherent to these patients' tumours. | |
dc.identifier.citation | Br J Cancer, vol.103(5), pp.656 - 662 | |
dc.identifier.doi | 10.1038/sj.bjc.6605817 | |
dc.identifier.issn | 1532-1827 | |
dc.identifier.uri | https://hdl.handle.net/10292/8222 | |
dc.language | eng | |
dc.publisher | Nature Publishing Group | |
dc.relation.uri | http://dx.doi.org/10.1038/sj.bjc.6605817 | |
dc.rights | From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. | |
dc.rights.accessrights | OpenAccess | |
dc.subject | Antineoplastic combined chemotherapy protocols | |
dc.subject | Busulfan | |
dc.subject | Cisplatin | |
dc.subject | Deoxycytidine | |
dc.subject | Drug resistance | |
dc.subject | Neoplasm | |
dc.subject | Drug screening assays | |
dc.subject | Antitumor | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Ovarian neoplasms | |
dc.subject | Topotecan | |
dc.title | Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy | |
dc.type | Journal Article | |
pubs.elements-id | 36025 | |
pubs.organisational-data | /AUT | |
pubs.organisational-data | /AUT/Design & Creative Technologies |